Literature DB >> 19635443

Effect of phenotypic switching on expression of virulence factors by Candida albicans causing candidiasis in diabetic patients.

Georgy Antony1, Vishwas Saralaya, K Gopalkrishna Bhat, M Shalini Shenoy, P G Shivananda.   

Abstract

A total of 110 strains belonging to seven species of Candida were isolated from various forms of candidiasis in diabetic patients. They were Candida albicans 53 (47%), Candida tropicalis 36 (33%), Candida glabrata 9 (8%), Candida parapsilosis 4 (4%), Candida guilliermondii 2 (2%), Candida krusei 5 (5%) and Candida kefyr 1 (1%). All 53 strains of C. albicans isolated were observed to express virulence factors such as cell surface hydrophobicity (CSH), adherence to human buccal epithelial cell (BEC) and proteinase activity (100%), while phospholipase activity was observed in 52 (98%). Phenotypic switching and its influence on the pathogenicity of C. albicans were studied. Two C. albicans strains isolated from oral and vaginal thrush, respectively, in diabetic individuals, and the control strain C. albicans NCPF 3153A were induced to undergo phenotypic switching by exposure to UV light and the degree of expression of virulence factors by the different morphological forms was determined. Three different morphological forms of C. albicans were obtained, namely Star (S), Wrinkled (W) and Ring (R) types from the original Smooth (O) variety. It was found that proteinase activity was greatest with the W type followed by the R type then the O type. The S type produced the least proteinase. The phospholipase activity was greatest with O type followed by R type. The W and S types produced the least phospholipase. Expression of CSH and adherence was greatest in the O type followed by the R and then the W type and finally the S type. Differential expression of virulence factors occurs with different phenotypic forms of C. albicans and this may provide a particular morphological type with a distinct advantage over other types in causing candidiasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19635443     DOI: 10.1016/j.riam.2009.03.001

Source DB:  PubMed          Journal:  Rev Iberoam Micol        ISSN: 1130-1406            Impact factor:   1.044


  6 in total

1.  Saccharomyces cerevisiae vaginitis: microbiology and in vitro antifungal susceptibility.

Authors:  María Julia Echeverría-Irigoyen; Elena Eraso; Josep Cano; María Gomáriz; Josep Guarro; Guillermo Quindós
Journal:  Mycopathologia       Date:  2011-03-22       Impact factor: 2.574

Review 2.  Candiduria; a review article with specific data from Iran.

Authors:  Maral Gharaghani; Simin Taghipour; Marzieh Halvaeezadeh; Ali Zarei Mahmoudabadi
Journal:  Turk J Urol       Date:  2018-11

3.  Differential adherence and expression of virulence traits by Candida albicans and Candida parapsilosis in mono- and dual-species cultures in artificial saliva.

Authors:  C L Seabra; C M Botelho; M Henriques; R Oliveira
Journal:  Mycopathologia       Date:  2013-05-10       Impact factor: 2.574

4.  Prevalence and Antifungal Susceptibility Profile of Clinically Relevant Candida Species in Postmenopausal Women with Diabetes.

Authors:  Sarah Al Halteet; Ahmed Abdel-Hadi; Mohamed Hassan; Mohamed Awad
Journal:  Biomed Res Int       Date:  2020-11-26       Impact factor: 3.411

5.  The APSES transcription factor Efg1 is a global regulator that controls morphogenesis and biofilm formation in Candida parapsilosis.

Authors:  Leona A Connolly; Alessandro Riccombeni; Zsuzsana Grózer; Linda M Holland; Denise B Lynch; David R Andes; Attila Gácser; Geraldine Butler
Journal:  Mol Microbiol       Date:  2013-08-15       Impact factor: 3.501

6.  Examining the anti-candidal activity of 10 selected Indian herbs and investigating the effect of Lawsonia inermis extract on germ tube formation, protease, phospholipase, and aspartate dehydrogenase enzyme activity in Candida albicans.

Authors:  Sripathy Ravichandran; Sundararaman Muthuraman
Journal:  Indian J Pharmacol       Date:  2016 Jan-Feb       Impact factor: 1.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.